13 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
28435528	24	Discovery of Highly Selective Inhibitors of the Immunoproteasome Low Molecular Mass Polypeptide 2 (LMP2) Subunit.	Kezar Life Sciences
25006746	85	Structure-based design ofß1i orß5i specific inhibitors of human immunoproteasomes.	Leiden Institute of Chemistry and Netherlands Proteomics Centre
32189500	56	LMP2 Inhibitors as a Potential Treatment for Alzheimer's Disease.	University of Kentucky
30611983	48	Exploration of novel macrocyclic dipeptide N-benzyl amides as proteasome inhibitors.	Zhejiang University
30380863	196	Required Immunoproteasome Subunit Inhibition Profile for Anti-Inflammatory Efficacy and Clinical Candidate KZR-616 ((2 S,3 R)- N-(( S)-3-(Cyclopent-1-en-1-yl)-1-(( R)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-hydroxy-3-(4-methoxyphenyl)-2-(( S)-2-(2-morpholinoacetamido)propanamido)propenamide).	Kezar Life Sciences
31521028	67	Immunoproteasome-selective inhibitors: An overview of recent developments as potential drugs for hematologic malignancies and autoimmune diseases.	Hangzhou Xixi Hospital
30964987	13	Development of Novel Epoxyketone-Based Proteasome Inhibitors as a Strategy To Overcome Cancer Resistance to Carfilzomib and Bortezomib.	University of Kentucky
30657666	263	Structure-Based Design of Inhibitors Selective for Human Proteasome ?2c or ?2i Subunits.	Leiden Institute of Chemistry and Netherlands Proteomics Centre
30455150	10	Tetradehydrohalicyclamine B, a new proteasome inhibitor from the marine sponge Acanthostrongylophora ingens.	Kumamoto University
29339252	124	Structure-based design of human immuno- and constitutive proteasomes inhibitors.	Universit£